A retrospective review of pregnancies in our psoriasis biologic cohort

This review assesses the real-world pregnancy outcomes of 15 pregnancies occurring while on biologic therapy in our psoriasis cohort over a 10-year period. Of the 15 pregnancies, there were 9 successful pregnancies, 4 first trimester miscarriages, 1 stillbirth at 28 weeks and 1 termination of pregnancy. Our study shows that the majority of pregnancies were successful; this reinforces previously published data that biologic therapy for psoriasis in pregnancy does not carry additional significant clinical risk, and contributes to the body of evidence supporting the safety of biologic therapy in pregnancy.